Abstract | BACKGROUND: OBJECTIVE: METHODS: Twenty-four subjects with atopic dermatitis received either doxepin or doxepin/TAC cream 4 times daily for 7 days in a randomized, double-blind, controlled trial. Serum samples were obtained and pharmacokinetic parameters estimated from the dose-normalized serum concentrations of doxepin and desmethyldoxepin. Efficacy and adverse experiences were determined by physician and subject evaluations. RESULTS: Pharmacokinetic parameters (K(e ), t(1/2 ) and AUC) calculated in 9 subjects ( doxepin/TAC = 4 subjects, doxepin = 5 subjects) with detectable serum concentrations were similar for both groups. Pruritus relief and lessening of pruritus severity were significantly greater with doxepin/TAC than doxepin alone. CONCLUSION:
|
Authors | L A Drake, L Cohen, R Gillies, J G Flood, A T Riordan, S B Phillips, M J Stiller |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 41
Issue 2 Pt 1
Pg. 209-14
(Aug 1999)
ISSN: 0190-9622 [Print] United States |
PMID | 10426891
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents
- Antipruritics
- Drug Combinations
- Ointments
- Doxepin
- Triamcinolone Acetonide
- desmethyldoxepin
|
Topics |
- Administration, Topical
- Adult
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Antipruritics
(administration & dosage, pharmacokinetics, therapeutic use)
- Dermatitis, Atopic
(drug therapy)
- Double-Blind Method
- Doxepin
(administration & dosage, analogs & derivatives, pharmacokinetics, therapeutic use)
- Drug Combinations
- Female
- Humans
- Male
- Ointments
- Triamcinolone Acetonide
(administration & dosage, therapeutic use)
|